功能性冠脉造影指导STEMI完全血运重建
国际随机试验纳入1823例STEMI多支病变且罪犯病变已成功处理的患者,随机分为功能学冠脉造影指导组(913例)和常规造影指导组(910例)。中位随访17.9个月,功能学指导组主要终点事件(全因死亡、心梗、脑血管事件或缺血驱动血运重建)发生率为8.9%,常规造影组为13.7%(HR 0.62;95%CI 0.47-0.83;P<0.001)。主要安全终点(对比剂相关急性肾损伤或大出血)功能学组4.6% vs 常规组7.1%(HR 0.63;95%CI 0.43-0.93;P=0.02)。
要点
- STEMI多支病变患者,罪犯病变成功处理后,功能学造影指导完全血运重建较常规造影降低主要终点事件(8.9% vs 13.7%,HR 0.62;95%CI 0.47-0.83)。
- 主要安全终点(对比剂相关急性肾损伤或大出血)功能学指导组更低(4.6% vs 7.1%,HR 0.63;95%CI 0.43-0.93;P=0.02)。
- 中位随访17.9个月,主要终点为全因死亡、心梗、脑血管事件(卒中或TIA)或缺血驱动血运重建的复合终点。
- 适用人群为STEMI合并多支病变且罪犯病变已成功治疗者,中位年龄66岁,24%为女性。
适用人群与场景
- STEMI合并多支冠状动脉病变、且罪犯病变已成功治疗的患者;中位年龄66岁(IQR 58-76),24%为女性。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 对STEMI多支病变且罪犯病变已成功治疗者,采用功能学冠脉造影指导非罪犯病变的血运重建决策,而非仅凭常规造影。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 国际随机试验,1823例STEMI多支病变患者随机分为功能学造影指导组(913例)和常规造影指导组(910例)。
- 主要终点(全因死亡、心梗、脑血管事件或缺血驱动血运重建)功能学组8.9% vs 常规组13.7%(HR 0.62;95%CI 0.47-0.83;P<0.001),中位随访17.9个月。
- 主要安全终点(对比剂相关急性肾损伤或大出血)功能学组4.6% vs 常规组7.1%(HR 0.63;95%CI 0.43-0.93;P=0.02)。
证据类型、等级与局限
- 随机对照试验(RCT),国际多中心;局限:原文未明确提及盲法及单中心/多中心具体数量。
对床旁实践的改变
- 支持在STEMI多支病变患者罪犯病变处理后,采用功能学冠脉造影指导完全血运重建以降低主要不良事件和对比剂相关急性肾损伤或大出血风险。
指南或共识出处
- AIR-STEMI试验(ClinicalTrials.gov NCT05818475),由意大利卫生部等资助;原文未提供指南名称。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Complete coronary-artery revascularization is recommended in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, but the preferred strategy for identifying nonculprit lesions that warrant treatment remains uncertain.
METHODS: In this international, randomized trial, we assigned patients with STEMI and multivessel disease in whom the culprit lesion had been successfully treated to undergo complete coronary-artery revascularization guided by functional coronary angiography (physiology-guided group) or by conventional angiography (angiography-guided group). The primary outcome was a composite of death from any cause, myocardial infarction, cerebrovascular accident (stroke or transient ischemic attack), or ischemia-driven revascularization, assessed in a time-to-event analysis. The primary safety outcome was a composite of contrast-associated acute kidney injury or major bleeding.
RESULTS: A total of 1823 patients underwent randomization; 913 were assigned to the physiology-guided group and 910 assigned to the angiography-guided group. The median age of the patients was 66 years (interquartile range, 58 to 76), and 24% were women. At a median follow-up of 17.9 months, a primary-outcome event had occurred in 81 patients (8.9%) in the physiology-guided group and in 125 patients (13.7%) in the angiography-guided group (hazard ratio, 0.62; 95% confidence interval [CI], 0.47 to 0.83; P<0.001). A primary-safety-outcome event occurred in 42 patients (4.6%) in the physiology-guided group and in 65 patients (7.1%) in the angiography-guided group (hazard ratio, 0.63; 95% CI, 0.43 to 0.93; P = 0.02).
CONCLUSIONS: In patients with STEMI and multivessel coronary artery disease, a strategy of complete coronary-artery revascularization guided by functional coronary angiography resulted in a lower risk of a primary-outcome event (death, myocardial infarction, cerebrovascular accident, or ischemia-driven revascularization) than a strategy guided by conventional angiography. (Funded by the Italian Health Ministry and others; AIR-STEMI ClinicalTrials.gov number, NCT05818475.).
参考来源
- Biscaglia S, Erriquez A, Colaiori I, et al. Complete Revascularization Guided by Functional Coronary Angiography in STEMI. N Engl J Med. 2026. PMID: 42670979. doi:10.1056/NEJMoa2605373
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。